Gene expression signatures in pre- and post-therapy (Rx) specimens from CALGB 40601 (Alliance), a neoadjuvant phase III trial of weekly paclitaxel and trastuzumab with or without lapatinib for HER2-positive breast cancer (BrCa) Meeting Abstract

  

Authors:	Carey, L. A.; Barry, W. T.; Pitcher, B.; Hoadley, K. A.; Cheang, M. C. U.; Anders, C. K.; Henry, N. L.; Tolaney, S. M.; Dang, C. T.; Krop, I. E.; Harris, L. S.; Berry, D. A.; Perou, C. M.; Winer, E. P.; Hudis, C. A.
Abstract Title:	Gene expression signatures in pre- and post-therapy (Rx) specimens from CALGB 40601 (Alliance), a neoadjuvant phase III trial of weekly paclitaxel and trastuzumab with or without lapatinib for HER2-positive breast cancer (BrCa)
Meeting Title:	50th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	32
Issue:	15 Suppl.
Meeting Dates:	2014 May 30-Jun 3
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2014-05-20
Language:	English
ACCESSION:	WOS:000358613202280
PROVIDER:	wos
DOI:	10.1200/jco.2014.32.15_suppl.506
Notes:	Meeting Abstract: 506 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/80861